4.7 Article

Clinical and pathogenic significance of S100A4 overexpression in systemic sclerosis

Related references

Note: Only part of the references are listed.
Article Multidisciplinary Sciences

Single-cell analysis of human glioma and immune cells identifies S100A4 as an immunotherapy target

Nourhan Abdelfattah et al.

Summary: This study identifies molecular phenotypes of immune-suppressive and -promoting myeloid cells in GBM through single cell RNA sequencing and discovers S100A4 as a regulator of immune suppressive T and myeloid cells in GBM. The study reveals extensive spatial and molecular heterogeneity in immune infiltrates and identifies nine distinct myeloid cell subtypes, with five being prognostic indicators of glioma patient survival.

NATURE COMMUNICATIONS (2022)

Article Rheumatology

Integrated analysis of dermal blister fluid proteomics and genome-wide skin gene expression in systemic sclerosis: an observational study

Kristina E. N. Clark et al.

Summary: This study conducted transcriptomic and proteomic analyses on blood and skin samples from patients with systemic sclerosis. Through identifying key hub analytes in skin and blister fluid modules, potential plasma protein biomarkers correlated with disease severity were discovered, offering a promising alternative to clinical scoring methods.

LANCET RHEUMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Combinatorial treatment with statins and niclosamide prevents CRC dissemination by unhinging the MACC1-β-catenin-S100A4 axis of metastasis

Benedikt Kortuem et al.

Summary: Colorectal cancer is the second most common malignant disease worldwide, and metastasis is the main cause of death in CRC patients. The study identified MACC1 and S100A4 as key genes promoting CRC metastasis and found repositioned drugs that can inhibit metastasis.

ONCOGENE (2022)

Article Cell Biology

Pharmacological Inhibition of S100A4 Attenuates Fibroblast Activation and Renal Fibrosis

Jia Wen et al.

Summary: S100A4 plays an important role in kidney fibrosis and promotes TGF-beta signaling through interaction with Smad3.

CELLS (2022)

Article Physiology

Hyaluronan/CD44 axis regulates S100A4-mediated mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis

Hong Xia et al.

Summary: Despite recent advances in pharmacotherapy targeting fibrogenic signaling pathways, idiopathic pulmonary fibrosis (IPF) remains a major unsolved clinical problem. This study reveals that the mechanism involving hyaluronan and CD44 contributes to the fibrogenicity of IPF mesenchymal progenitor cells (MPCs), shedding light on potential targets for therapeutic interventions in IPF.

AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2021)

Review Rheumatology

Advances in epigenetics in systemic sclerosis: molecular mechanisms and therapeutic potential

Pei-Suen Tsou et al.

Summary: Systemic sclerosis (SSc) is a complex inflammatory fibrotic disease with unknown etiology and partially understood pathogenesis, carrying the highest mortality rate among rheumatic diseases. Epigenetic aberrations play a crucial role in SSc pathogenesis, affecting immune cells, endothelial cells, and fibroblasts, presenting potential new avenues for therapeutic interventions.

NATURE REVIEWS RHEUMATOLOGY (2021)

Article Developmental Biology

Generation of an Fsp1 (fibroblast-specific protein 1)-Flpo transgenic mouse strain

Victoire Cardot-Ruffino et al.

GENESIS (2020)

Review Cell Biology

Extracellular S100A4 as a key player in fibrotic diseases

Zhenzhen Li et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)

Article Cardiac & Cardiovascular Systems

The S100 calcium-binding protein A4 level is elevated in the lungs of patients with idiopathic pulmonary fibrosis

Jong-Uk Lee et al.

RESPIRATORY MEDICINE (2020)

Article Multidisciplinary Sciences

Identification of a pro-angiogenic functional role for FSP1-positive fibroblast subtype in wound healing

Sarika Saraswati et al.

NATURE COMMUNICATIONS (2019)

Review Immunology

Damage-Associated Molecular Patterns in Inflammatory Diseases

Jong Seong Roh et al.

IMMUNE NETWORK (2018)

Article Medicine, Research & Experimental

Calcium-binding protein S100A4 confers mesenchymal progenitor cell fibrogenicity in idiopathic pulmonary fibrosis

Hong Xia et al.

JOURNAL OF CLINICAL INVESTIGATION (2017)

Review Medicine, General & Internal

Systemic sclerosis

Christopher P. Denton et al.

LANCET (2017)

Article Biochemistry & Molecular Biology

Extracellular S100A4 affects endothelial cell integrity and stimulates transmigration of A375 melanoma cells

Nadine Herwig et al.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2016)

Article Medicine, General & Internal

Systemic sclerosis

Yannick Allanore et al.

NATURE REVIEWS DISEASE PRIMERS (2015)

Article Rheumatology

S100A4 amplifies TGF-β-induced fibroblast activation in systemic sclerosis

Michal Tomcik et al.

ANNALS OF THE RHEUMATIC DISEASES (2015)

Review Oncology

S100 proteins in cancer

Anne R. Bresnick et al.

NATURE REVIEWS CANCER (2015)

Article Biochemistry & Molecular Biology

Identification of human epididymis protein-4 as a fibroblast-derived mediator of fibrosis

Valerie S. LeBleu et al.

NATURE MEDICINE (2013)

Article Multidisciplinary Sciences

Metastasis-Inducing S100A4 and RANTES Cooperate in Promoting Tumor Progression in Mice

Birgitte Forst et al.

PLOS ONE (2010)